SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Clinical trials for SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED trials appear
Sign up with your email to follow new studies for SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered T-Cells take on viruses in cancer patients: a new hope?
Disease control Recruiting nowThis early-stage trial tests whether specially designed immune cells (T-cells) can safely control serious viral infections in cancer patients whose immune systems are weakened by treatment. The cells are modified to target specific viruses like CMV, BK virus, or COVID-19. The stu…
Matched conditions: SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Cord blood stem cells could tame COVID lung crisis
Disease control Recruiting nowThis study tests whether infusions of stem cells from donated umbilical cord blood can help people with moderate to critical COVID-19 pneumonia. The stem cells are grown in a lab and given to reduce lung inflammation and improve breathing. About 70 adults with COVID-19 and relate…
Matched conditions: SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:47 UTC